New Yorker scores points off FDA’s Galson
Executive Summary
Acting CDER Director Steven Galson, MD, is the subject of a question in a tongue-in-cheek quiz by Paul Slansky in The New Yorker Aug. 30 focusing on the Bush Administration. The description matched to Galson's name: "the federal drug official who rejected the 23-4 recommendation of an advisory panel and refused to allow a morning-after birth-control pill to be sold over the counter" (1"The Pink Sheet" May 10, 2004, p. 6)...
You may also be interested in...
Plan B “Not Approvable” Decision Puts FDA, CDER Director In Hot Seat
FDA's "not approvable" decision for Barr Labs' emergency contraceptive Plan B over-the-counter switch puts the agency back in the spotlight of presidential campaign politics
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.